Crosignani A - Search Results

1

Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.

Crosignani A, Podda M, Bertolini E, Battezzati PM, Zuin M, Setchell KD. Crosignani A, et al. Hepatology. 1991 Jun;13(6):1076-83. Hepatology. 1991. PMID: 2050325

2

Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.

Colombo C, Crosignani A, Assaisso M, Battezzati PM, Podda M, Giunta A, Zimmer-Nechemias L, Setchell KD. Colombo C, et al. Among authors: crosignani a. Hepatology. 1992 Oct;16(4):924-30. doi: 10.1002/hep.1840160412. Hepatology. 1992. PMID: 1398498 Clinical Trial.

3

Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study.

Crosignani A, Battezzati PM, Setchell KD, Camisasca M, Bertolini E, Roda A, Zuin M, Podda M. Crosignani A, et al. Hepatology. 1991 Feb;13(2):339-44. Hepatology. 1991. PMID: 1671665 Clinical Trial.

4

Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones.

Zuin M, Petroni ML, Grandinetti G, Crosignani A, Bertolini E, Battezzati PM, Podda M. Zuin M, et al. Among authors: crosignani a. Scand J Gastroenterol. 1991 Mar;26(3):257-62. doi: 10.3109/00365529109025039. Scand J Gastroenterol. 1991. PMID: 1853147 Clinical Trial.

5

Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.

Crosignani A, Podda M, Battezzati PM, Bertolini E, Zuin M, Watson D, Setchell KD. Crosignani A, et al. Hepatology. 1991 Dec;14(6):1000-7. Hepatology. 1991. PMID: 1959845

6

Effects of taurine and ursodeoxycholic acid on liver function tests in patients with cystic fibrosis.

Colombo C, Battezzati PM, Crosignani A, Assaisso M, Ronchi M, Giunta A. Colombo C, et al. Among authors: crosignani a. Acta Univ Carol Med (Praha). 1990;36(1-4):148-51. Acta Univ Carol Med (Praha). 1990. PMID: 2130679

7

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.

Colombo C, Setchell KD, Podda M, Crosignani A, Roda A, Curcio L, Ronchi M, Giunta A. Colombo C, et al. Among authors: crosignani a. J Pediatr. 1990 Sep;117(3):482-9. doi: 10.1016/s0022-3476(05)81103-5. J Pediatr. 1990. PMID: 2391610

8

Effect of different doses of ursodeoxycholic acid in chronic liver disease.

Podda M, Ghezzi C, Battezzati PM, Bertolini E, Crosignani A, Petroni ML, Zuin M. Podda M, et al. Among authors: crosignani a. Dig Dis Sci. 1989 Dec;34(12 Suppl):59S-65S. doi: 10.1007/BF01536665. Dig Dis Sci. 1989. PMID: 2598769 Clinical Trial.

9

Ursodeoxycholic acid for chronic liver diseases.

Podda M, Ghezzi C, Battezzati PM, Bertolini E, Crosignani A, Petroni ML, Zuin M. Podda M, et al. Among authors: crosignani a. J Clin Gastroenterol. 1988;10 Suppl 2:S25-31. J Clin Gastroenterol. 1988. PMID: 3062082 Review.

10

Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis.

Camisasca M, Crosignani A, Battezzati PM, Albisetti W, Grandinetti G, Pietrogrande L, Biffi A, Zuin M, Podda M. Camisasca M, et al. Among authors: crosignani a. Hepatology. 1994 Sep;20(3):633-7. Hepatology. 1994. PMID: 8076921 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters